The Department of Defense (DoD) is offering the Prostate Cancer Idea Development Award, a grant designed to support new, innovative, and high-risk/high-gain approaches in prostate cancer research. This grant is for the purpose of fostering groundbreaking ideas with the potential to make significant contributions toward eliminating death and suffering from prostate cancer. A preproposal is mandatory, with full applications submitted by invitation only. While preliminary data are encouraged, they are not required. The most crucial review criteria are innovation and impact. It is important to note that this award does not fund clinical trials. A New Investigator Option is also available for those early in their faculty appointments or developing independent research careers.
Opportunity ID: 156553
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-12-PCRP-IDA |
| Funding Opportunity Title: | DoD Prostate Cancer Idea Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 30 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 20, 2012 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Aug 09, 2012 |
| Current Closing Date for Applications: | Aug 09, 2012 |
| Archive Date: | Sep 08, 2012 |
| Estimated Total Program Funding: | $14,900,000 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | Preproposal is required; application submission is by invitation only. Supports new ideas that represent innovative, high-risk/high-gain approaches to prostate cancer research, and have the potential to make an important contribution to eliminating death and suffering from prostate cancer. Preliminary data are encouraged but not required. Innovation and Impact are the most important review criteria. Does not support clinical trials. New Investigator Option supports applicants early in their faculty appointments or in the process of developing independent research careers. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk: 301-682-5507
Email:help@cdmrp.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 156553 Full Announcement-1 -> fy12 cdmrp gai final 12mar2012.pdf
Folder 156553 Full Announcement-1 -> pcrp_fy12_ida_pa_gg.pdf
Folder 156553 Full Announcement-1 -> pcrp_fy12_ida-nio_statement_of_independence.pdf
Folder 156553 Full Announcement-1 -> pcrp_fy12_ida-nio_eligibility statement.pdf
Packages
| Agency Contact Information: | CDMRP Help Desk: 301-682-5507 Email: help@cdmrp.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00108930 | Mar 20, 2012 | Aug 09, 2012 | View |
Package 1
Mandatory forms
156553 RR_SF424_1_2-1.2.pdf
156553 PerformanceSite_1_4-1.4.pdf
156553 RR_Budget-1.1.pdf
156553 RR_KeyPersonExpanded_1_2-1.2.pdf
Optional forms
156553 RR_SubawardBudget30-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
